Loading...
Keppra, Keppra XR, Spritam
Antiepileptic • SV2A modulator
Binds to synaptic vesicle protein SV2A, modulating neurotransmitter release
Drug Class
Antiepileptic
Subclass
SV2A modulator
Half-life
6-8 hours
Time for plasma concentration to decrease by 50%
Protein Binding
<10%
Fraction bound to plasma proteins
Therapeutic Index
Wide
Margin between therapeutic and toxic doses